搜索
Search
Online customer service
Customer service hotline
020-32290909 020-32290909
Service time:
8:00 - 16:00
Customer service group:
在线客服

BUSINESS CENTER

BUSINESS CENTER

业务中心

PRODUCT CENTER

PRODUCT CENTER

产品中心

Impurity Reference Substance
View more ▶

ABOUT US

公司简介

Guangzhou HC Pharmaceutical Co.Ltd.

Guangzhou HC Pharmaceutical Co., Ltd. was founded in 2011 and is located in the Phipes health industry park in Guangzhou. With a research and development area of nearly 8000 square meters, it is a high-tech enterprise that provides comprehensive pharmaceutical research and development services. The company is jointly established by a drug research and development professional team and overseas and domestic students. Mainly engaged in the research and development of new drugs and generic drugs, CDMO services for sterile raw materials, customization of impurity reference materials, confirmation of unknown impurity structures, and research services for genotoxic impurities; Import drug registration agency, drug declaration in Europe and America, and market promotion. Familiar with the drug registration and import and export business in China and Europe, as well as the research and development capabilities, process technology improvement capabilities, and industrialization implementation capabilities. Strong business relations with multiple large pharmaceutical companies both domestically and internationally.

关于我们

NEWS

NEWS

新闻资讯

Yesterday, there was good news again from Guangzhou Aiqixi. In the drug approval certificate information released by NMPA on September 27, 2022, our company undertook the consistency evaluation project of "Ceftazidime for Injection" for two clients and officially passed the CDE review.
On July 13, 2022, Chen Jijian, Director of the Guangzhou Market Supervision and Administration Bureau, and a delegation visited Guangzhou Aiqixi for guidance and guidance. Aiqixi Chairman Lin Lidong and R&D Director Yao Liuduan warmly introduced and accompanied the visit throughout the entire process.
On August 3, 2022, Ou Yonghua, Deputy Director of the Industry and Information Technology Bureau of Huangpu District, Guangzhou, and his delegation visited Guangzhou Aiqixi to guide work and present preferential policies to enterprises. Aiqixi Chairman Lin Lidong and General Manager Feng Shengxi accompanied the entire visit and introduction.
On August 8, 2022, Director Li Ning and his delegation from the Administrative Approval Bureau of Guangzhou Development Zone visited Guangzhou Aiqixi on site, accompanied by Chairman Lin Lidong and General Manager Feng Shengxi throughout the entire process.
On August 29, 2022, the Jiangsu Youth Science and Technology Achievements Direct Train (Yixing Station) and the Third Yixing the Taihu Lake Bay International Youth Elite Science and Innovation Challenge Award Ceremony were held. Si Yong, secretary of the provincial Communist Youth League Committee, Zhang Yingchun, deputy secretary of the provincial Communist Youth League Committee and chairman of the provincial youth federation, Lu Min, deputy mayor of Wuxi, and Shen Xiaohong, Qian Yi, and Jin Lei, municipal leaders, participated in the event.
Yesterday, there was good news again from Guangzhou Aiqixi. In the drug approval certificate information released by NMPA on September 27, 2022, our company undertook the consistency evaluation project of "Ceftazidime for Injection" for two clients and officially passed the CDE review.

2022

07-18

On July 13, 2022, Chen Jijian, Director of the Guangzhou Market Supervision and Administration Bureau, and a delegation visited Guangzhou Aiqixi for guidance and guidance. Aiqixi Chairman Lin Lidong and R&D Director Yao Liuduan warmly introduced and accompanied the visit throughout the entire process.

2022

08-05

On August 3, 2022, Ou Yonghua, Deputy Director of the Industry and Information Technology Bureau of Huangpu District, Guangzhou, and his delegation visited Guangzhou Aiqixi to guide work and present preferential policies to enterprises. Aiqixi Chairman Lin Lidong and General Manager Feng Shengxi accompanied the entire visit and introduction.

2022

08-10

On August 8, 2022, Director Li Ning and his delegation from the Administrative Approval Bureau of Guangzhou Development Zone visited Guangzhou Aiqixi on site, accompanied by Chairman Lin Lidong and General Manager Feng Shengxi throughout the entire process.

2022

09-14

On August 29, 2022, the Jiangsu Youth Science and Technology Achievements Direct Train (Yixing Station) and the Third Yixing the Taihu Lake Bay International Youth Elite Science and Innovation Challenge Award Ceremony were held. Si Yong, secretary of the provincial Communist Youth League Committee, Zhang Yingchun, deputy secretary of the provincial Communist Youth League Committee and chairman of the provincial youth federation, Lu Min, deputy mayor of Wuxi, and Shen Xiaohong, Qian Yi, and Jin Lei, municipal leaders, participated in the event.

2022

08-10

On August 8, 2022, Director Li Ning and his delegation from the Administrative Approval Bureau of Guangzhou Development Zone visited Guangzhou Aiqixi on site, accompanied by Chairman Lin Lidong and General Manager Feng Shengxi throughout the entire process.

Contact us

Tel:020-32290909/+86-18026282712

E-mail:shiqilin@gzhc.com.cn

Add:11th to 13th floors, Building C, and 3rd floor, Building D,

Phipes health industry park, No. 288 Shenzhou Road, Huangpu District, Guangzhou, China

这是描述信息

Wechat official account

Copyright © 2019 Guangzhou HC Pharmaceutical Co. Ltd, All right reserved.    粤ICP备2022127745号    Technical support: Xinnet

营业执照

Business License